Metraipolis › archive › dc_56757ce23887
deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types — Europe PMC PMID:41601354
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41601354
- DOI
- 10.1002/ctm2.70595
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T09:24:46.947Z
- SHA-256 of the archived text
670e116c7d0dbe075dfbce8e6ea1d23a00ed27c61f34d7bf94289a0a69d7d9b2- Stable URL of this page
https://metraipolis.com/documento/dc_56757ce23887
How to cite
deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types — Europe PMC PMID:41601354 — Europe PMC (en), https://europepmc.org/article/MED/41601354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56757ce23887 (Metraipolis archive dc_56757ce23887, sha256 670e116c7d0dbe075dfbce8e6ea1d23a00ed27c61f34d7bf94289a0a69d7d9b2)
BibTeX
@misc{dc56757ce23887,
title = {deltaHED predicts survival and immune evasion in PD-1 blockade therapy: A multi-cohort study across three cancer types — Europe PMC PMID:41601354},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41601354},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56757ce23887; sha256 670e116c7d0dbe075dfbce8e6ea1d23a00ed27c61f34d7bf94289a0a69d7d9b2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601354. Agents can read the archived copy with the MCP tool read_document.